Biological responses of human mesenchymal stem cells to titanium wear debris particles

Journal of Orthopaedic Research

Volumn 30, Issue 6, 2012, Pages 853-863

  Haleem Smith, Hana ^a   Argintar, Evan ^a,b   Bush, Curtis ^a,b   Hampton, Daniel ^a,b   Postma, William F ^a,b   Chen, Faye H ^a   Rimington, Todd ^a,b   Lamb, Joshua ^a,b   Tuan, Rocky S ^a,b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adult stem cells; Apoptosis; Cell adhesion; Cell proliferation; Cytokines; Cytoskeleton; Endocytosis; Implant wear

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TITANIUM; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL JUNCTION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSKELETON; ENDOCYTOSIS; HUMAN; HUMAN TISSUE; IMPLANT; MECHANICAL STRESS; MESENCHYMAL STEM CELL; PRIORITY JOURNAL;

ADHERENS JUNCTIONS; APOPTOSIS; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MESENCHYMAL STEM CELLS; OSTEOGENESIS; OSTEOLYSIS; PARTICULATE MATTER; TITANIUM;

EID: 84859631236     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22002     Document Type: Article

References (51)

1. Kurtz S, Mowat F, Ong K, et al. 2005. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002 J Bone Joint Surg Am 87:1487-1497. (Pubitemid 40917748)
2. Bozic KJ, Kurtz SM, Lau E, et al. 2009. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 91:128-133.
3. Abu-Amer Y, Darwech I, Clohisy J. 2007. Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthr Res Ther 9:S6.
4. Tuan RS, Lee FY, T Konttinen Y, et al. 2008. What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles? J Am Acad Orthop Surg 16:S42-S48.
5. Hundric-Haspl Z, Pecina M, Haspel M. 2006. Plasma cytokines as markers of aseptic prosthesis loosening. Clinl Orthop Rel Res 453:299-304. (Pubitemid 44900997)
6. Wang ML, Nesti LJ, Tuli R, et al. 2002. Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 20:1175-1184. (Pubitemid 35363974)
7. Wang ML, Tuli R, Manner PA, et al. 2003. Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res 21:697-707. (Pubitemid 36758214)
8. Okafor CC, Haleem-Smith H, Laquerierre P, et al. 2006. Particulate endocytosis mediates biological responses of human mesenchymal stem cells to titanium wear debris. J Orthop Res 24:461-473. (Pubitemid 43773009)
9. Tuan RS. 2011. Role of adult stem/progenitor cells in osseointegration and implant loosening. Int J Oral Maxillofac Implants 26:50-56.
10. Schofer MD, Fuchs-Winkelmann S, Kessler-Thönes A, et al. 2008. The role of mesenchymal stem cells in the pathogenesis of Co-Cr-Mo particle induced aseptic loosening: an in vitro study. Biomed Mater Eng 18:395-403.
11. Chiu R, Ma T, Smith RL, et al. 2007. Kinetics of polymethylmethacrylate particle-induced inhibition of osteoprogenitor differentiation and proliferation. J Orthop Res 25:450-457. (Pubitemid 46542031)
12. Chiu R, Ma T, Smith RL, et al. 2008. Polymethylmethacrylate particles inhibit osteoblastic differentiation of MC3T3-E1 osteoprogenitor cells. J Orthop Res 26:932-936.
13. Chiu R, Ma T, Smith RL, et al. 2009. Ultrahigh molecular weight polyethylene wear debris inhibits osteoprogenitor proliferation and differentiation in vitro. J Biomed Mater Res A 89:242-247.
14. Chiu R, Smith KE, Ma GK, et al. 2010. Polymethylmethacrylate particles impair osteoprogenitor viability and expression of osteogenic transcription factors Runx2, osterix, and Dlx5. J Orthop Res 28:571-577.
15. Tuli R, Tuli S, Nandi S, et al. 2003. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 21:681-693. (Pubitemid 37329161)
16. Noth U, Osyczka AM, Tuli R, et al. 2002. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20:1060-1069.
17. Bi Y, Seabold JM, Kaar SG, et al. 2001. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 16:2082-2091. (Pubitemid 32995400)
18. Boland GM, Perkins G, Hall DJ, et al. 2004. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93:1210-1230. (Pubitemid 44264134)
19. Piek E, Sleumer LS, van Someren EP, et al. 2010. Osteotranscriptomics of human mesenchymal stem cells: accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis. Bone 46:613-627.
20. Pricola KL, Kuhn NZ, Haleem-Smith H, et al. 2009. Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem 108:577-588.
21. Seldin DC, Adelman S, Austen KF, et al. 1985. Homology of the rat basophilic leukemia cell, the rat mucosal mast cell. Proc Natl Acad Sci USA 82:3871-3875. (Pubitemid 15246454)
22. Salvati EA, Betts F, Doty SB. 1993. Particulate metallic debris in cemented total hip arthroplasty. Clin Orthop Relat Res 293:160-173. (Pubitemid 23242865)
23. Jacobs JJ, Skipor AK, Patterson LM, et al. 1998. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg Am 80:1447-1458. (Pubitemid 28503259)
24. Buly RL, Huo MH, Salvati E, et al. 1992. Titanium wear debris in failed cemented total hip arthroplasty: an analysis of 71 cases. J Arthroplasty 7:315-323.
25. Rader CP, Sterner T, Jakob F, et al. 1999. Cytokine response of human macrophage-like cells after contact with polyethylene and pure titanium particles. J Arthroplasty 14:840-848. (Pubitemid 29483252)
26. Yao J, Cs-Szabo G, Jacobs JJ, et al. 1997. Suppression of osteoblast function by titanium particles. J Bone Joint Surg Am 79:107-112. (Pubitemid 27057457)
27. Pioletti DP, Takei H, Kwon SY, et al. 1999. The cytotoxic effect of titanium particles phagocytosed by osteoblasts. J Biomed Mater Res 46:399-407. (Pubitemid 29293764)
28. Kwon SY, Lin T, Takei H, et al. 2001. Alterations in the adhesion behavior of osteoblasts by titanium particle loading: inhibition of cell function and gene expression. Biorheology 38:161-183. (Pubitemid 32568537)
29. Fritz EA, Glant TT, Vermes C, et al. 2006. Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris. J Biomed Mater Res A 77:192-201.
30. Maoqiang L, Zhenan Z, Fengxiang L, et al. 2010. Enhancement of osteoblast differentiation that is inhibited by titanium particles through inactivation of NFATc1 by VIVIT peptide. J Biomed Mater Res A 95:727-734.
31. Lenz R, Mittelmeier W, Hansmann D, et al. 2009. Response of human osteoblasts exposed to wear particles generated at the interface of total hip stems and bone cement. J Biomed Mater Res A 89:370-378.
32. Lassus J, Waris V. Xu JW et al. 2000. Increased interleukin-8 (IL-8) expression is related to aseptic loosening of total hip replacement. Arch Orthop Trauma Surg 120:328-332. (Pubitemid 30255857)
33. Tanaka R, Yasunaga Y, Hisatome T, et al. 2005. Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J Arthroplasty 20:1049-1054. (Pubitemid 41820993)
34. Liu CH, Hwang SM. 2005. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32:270-279. (Pubitemid 43176649)
35. Yew TL, Hung YT, Li HY, et al. 2011. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell Transplant 20:693-706.
36. DelaRosa O, Lombardo E. 2010. Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential. Mediators Inflamm 2010:865601; Epub 2010 Jun 14.
37. Sumanasinghe RD, Pfeiler TW, Monteiro-Riviere NA, et al. 2009. Expression of proinflammatory cytokines by human mesenchymal stem cells in response to cyclic tensile strain. J Cell Physiol 219:77-83.
38. Nasser S, Campbell PA, Kilgus D, et al. 1990. Cementless total joint arthroplasty prostheses with titanium-alloy articular surfaces. A human retrieval analysis. Clin Orthop Relat Res 261:171-185.
39. Hernigou P, Intrator L, Bahrami T, et al. 1999. Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Section II. Clin Orthop Rel Res 366:147-154. (Pubitemid 29439348)
40. Daniel J, Ziaee H, Pradhan C, et al. 2010. Renal clearance of cobalt in relation to the use of metal-on-metal bearings in hip arthroplasty. Bone Joint Surg Am 92:840-845.
41. Delaunay C, Petit I, Learmonth ID, et al. 2010. Metal-onmetal bearings total hip arthroplasty: the cobalt and chromium ions release concern. Orthop Traumatol Surg Res 96:894-904.
42. Ricci WM, Gallagher B, Haidukewych GJ. 2009. Intramedullary nailing of femoral shaft fractures: current concepts. J Am Acad Orthop Surg 17:296-305.
43. Luu HH, Song W, Luo X, et al. 2007. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25:665-677. (Pubitemid 46730519)
44. Friedman MS, Long MW, Hankenson KD. 2006. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 98:538-554. (Pubitemid 43727174)
45. Grasser WA, Orlic I, Borovecki F, et al. 2007. BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways. Int Orthop 31:759-765. (Pubitemid 350160308)
46. Eswarakumar VP, Horowitz MC, Locklin R, et al. 2004. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci USA 101:12555-12560. (Pubitemid 39122062)
47. Li CF, Hughes-Fulford M. 2006. Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells. J Bone Miner Res 21:946-955. (Pubitemid 43788001)
48. Lee MS, Kim HS, Yeon JT, et al. 2009. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway. J Immunol 183:3390-3399.
49. Crisostomo PR, Wang Y, Markel TA, et al. 2008. Human mesenchymal stem cells stimulated by TNF-a, LPS, or hypoxia produce growth factors by an NFKB- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 294:C675-C682. (Pubitemid 351468685)
50. Kann S, Chiu R, Ma T, et al. 2010. OP-1 (BMP-7) stimulates osteoprogenitor cell differentiation in the presence of polymethylmethacrylate particles. J Biomed Mater Res A 94:485-488.
51. Ho JE, Chung EH, Wall S, et al. 2007. Immobilized sonic hedgehog N-terminal signaling domain enhances differentiation of bone marrow-derived mesenchymal stem cells. J Biomed Mater Res A 83:1200-1208. (Pubitemid 350231783)